Early treatment in HCV : is it a cost-utility option from the Italian perspective?

Marcellusi, Andrea, Viti, Raffaella, Damele, Francesco, Camma, Calogero, Taliani, Gloria and Mennini, Francesco Saverio (2016) Early treatment in HCV : is it a cost-utility option from the Italian perspective? Clinical Drug Investigation, 36(8), pp. 661-672. ISSN (print) 1173-2563

Official URL: http://dx.doi.org/10.1007/s40261-016-0414-y

Abstract

Our model represents a tool for policy makers and health-care professionals, and provided information on the cost-utility of the early-treatment approach in HCV-infected patients in Italy. Starting innovative treatment regimens earlier keeps HCV-infected patients in better health and reduces the incidence of HCV-related events; generating a gain both in terms of health of the patients and correct resource allocation.

Actions (Repository Editors)

Item Control Page